Work

Prognostic value of an MRI-derived recurrence assay in women with hormone receptor–positive, HER2-negative breast cancer: A retrospective, multi-center analysis.

Year: 2026

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2026.44.16_suppl.560

Authors: Matthew P. Goetz, Qinmei Xu, Vincent Reid, Hari Trivedi, Rohan Isaac, David Zahrieh, Tanya L. Hoskin, Jordan Campbell, Vignesh Kannan, Bradley Feiger, Daniel Cook, Joseph R. Peterson, Judy Caroline Boughey, Haruka Itakura

Institutions: Mayo Clinic, Stanford University, Mary Bird Perkins Cancer Center, Emory University Hospital, Emory University, Stanford Medicine

Language: English

Topic: MRI in cancer diagnosis

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7162552744

Cites:

Cited by:

Related to: